RDY·256135203·US·adr·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
ADR
RDY (DR. REDDY'S LABORATORIES-ADR) is held by 117 institutional investors as of Q4 2025. Largest holders: Robeco Institutional Asset Management B.V. ($237.9M), DIMENSIONAL FUND ADVISORS LP ($73.7M), UBS Group AG ($21.5M). Net institutional sentiment: Mixed.
See how RDY's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer